An interventional study of Pulmonary Rehabilitation Program and Conventional Exercise Program in Axial Spondyloarthritis and Ankylosing Spondylitis (AS), sponsored by Sisli Hamidiye Etfal Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Sisli Hamidiye Etfal Training and Research Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 84 studies in Spondylitis, Ankylosing with a site in Turkey — 19 open to participants now, 21 under way, none of them phase 3. Spondylitis, Ankylosing · Turkey.
Among the 84 studies in Spondylitis, Ankylosing with a site in Turkey, this one is the 37th largest by enrollment of the 49 interventional ones that give a count, is one of 9 that started in 2025, is one of 37 with no phase, and was the 80th registered.
535 studies on the registry are indexed under Spondylitis, Ankylosing; 100 are open to participants now.
Browse Spondylitis, Ankylosing studies →19 of the 84 studies in Spondylitis, Ankylosing with a site in Turkey are open now. Recruiting first, the newest first:
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 18–65
Ankara Etlik City Hospital · Sites in Turkey
Ages 18–65
Marmara University · Sites in Turkey
Ages 18–65
Merve Şahin · Sites in Turkey
Ages 18–65 · Healthy volunteers
Konya Beyhekim Training and Research Hospital · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 63 Spondylitis, Ankylosing studies recruiting now, 24 (38%) set no upper age limit and 33 (52%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
84 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 9 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 48 is below the median of 87 across 304 interventional studies indexed under Spondylitis, Ankylosing.
Median enrollment 60 across the 49 interventional studies, 100 across the 35 observational. Of the 54 that completed or were terminated, 11 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 84 have an industry lead sponsor. The 10 most frequent:
Sisli Hamidiye Etfal Training and Research Hospital is the lead sponsor of 114 studies on the registry; 13 are open to participants now.
Sisli Hamidiye Etfal Training and Research Hospital has 1 study filed under Spondylitis, Ankylosing — fewer than ten, so there is no comparison to draw.
9 of the studies in Spondylitis, Ankylosing with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07627542Merve ŞahinAn Investigation of the Effect of Smartphone Usage Levels on Cervical Posture, Tongue Pressure, Balance, and Neck Disability in Individuals With Rheumatoid Arthritis and Ankylosing Spondylitis | 2026-11 |
| NCT07170384Sinem Kübra BekeMediterranean Diet and Disease Activity in Axial Spondyloarthritis Receiving Biologic Therapy | 2027-01-01 |
| NCT07633730Marmara UniversityEfficacy of the Erector Spinae Plane Block for Persistent Back Pain in Patients With Ankylosing Spondylitis | 2027-05-02 |
| NCT05096767Bozyaka Training and Research HospitalNeuropathic Spinal Pain Descriptors in Ankylosing Spondylitis | 2027-05-05 |
| NCT07776652Istanbul University - CerrahpasaPostural Biofeedback and Exercise in Axial Spondyloarthritis | 2027-05-30 |
Add all 9 to your calendar (.ics) → With an account.
Among the 84 studies in Spondylitis, Ankylosing with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective, randomized, single-blind controlled study evaluates the effects of pulmonary rehabilitation exercises in patients with axial spondyloarthritis. Participants were randomized into two groups. The intervention group received a pulmonary rehabilitation program in addition to conventional exercises, while the control group received conventional exercises alone. The primary outcome was pain intensity assessed using the Visual Analog Scale (VAS). Additional assessments included exercise capacity, pulmonary function, disease activity, quality of life, spinal mobility, and chest expansion. Outcomes were evaluated at baseline, week 8, and week 12.
This is a single-center, prospective, randomized, single-blind controlled study conducted in patients with axial spondyloarthritis followed at the Physical Medicine and Rehabilitation Clinic of Sisli Hamidiye Etfal Training and Research Hospital.
Participants were randomized into two groups using the National Cancer Institute Clinical Trial Randomization Tool with the Maximally Tolerated Imbalance method. The intervention group received conventional exercises together with a structured pulmonary rehabilitation program. The pulmonary rehabilitation program included breathing exercises, range-of-motion exercises, aerobic exercise, and strengthening exercises.
Participants in the intervention group performed home-based range-of-motion and breathing exercises twice daily for 10 repetitions. Breathing exercises included pursed-lip breathing, diaphragmatic breathing, lateral abdominal breathing, relaxation and breathing control exercises, and neck and shoulder stretching exercises. In addition, participants completed supervised cycle ergometer exercise sessions at the hospital twice weekly for 8 weeks, with each session lasting approximately 30 minutes including warm-up and cool-down periods. Aerobic exercise intensity was prescribed at moderate intensity using the Karvonen method, with the Borg Rating of Perceived Exertion used when appropriate. Upper-extremity and shoulder-girdle strengthening exercises were also included.
The control group received a conventional exercise program.
The primary outcome was pain intensity measured using the Visual Analog Scale (VAS), with the primary endpoint defined as week 12. Secondary assessments included the Six-Minute Walk Test, Ankylosing Spondylitis Quality of Life Questionnaire, Maximum Voluntary Ventilation, pulmonary function tests, chest expansion, modified Schober distance, occiput-to-wall distance, lateral spinal flexion, Bath Ankylosing Spondylitis Disease Activity Index, and C-reactive protein. Assessments were performed at baseline, week 8, and week 12.
535 studies on the registry are indexed under Spondylitis, Ankylosing; 100 are open to participants now.
This study's enrollment of 48 is below the median of 87 across 304 interventional studies indexed under Spondylitis, Ankylosing.
Browse Spondylitis, Ankylosing studies →Sisli Hamidiye Etfal Training and Research Hospital is the lead sponsor of 114 studies on the registry; 13 are open to participants now.
Compared within Spondylitis, Ankylosing, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Axial Spondyloarthritis. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants received a structured pulmonary rehabilitation program in addition to conventional exercise for 8 weeks. The program included home-based breathing and range-of-motion exercises, supervised cycle ergometer exercise twice weekly, and upper-extremity and shoulder-girdle strengthening exercises.
Behavioral: Pulmonary Rehabilitation Program · Behavioral: Conventional Exercise Program
Participants performed a home-based conventional exercise program. Exercise instructions were provided by video recording, and participants attended face-to-face follow-up sessions once weekly.
Behavioral: Conventional Exercise Program
The pulmonary rehabilitation program was administered for 8 weeks in addition to conventional exercise. Participants performed home-based breathing and range-of-motion exercises twice daily for 10 repetitions. Breathing exercises included pursed-lip breathing, diaphragmatic breathing, lateral abdominal breathing, relaxation and breathing control exercises, and neck and shoulder stretching. Participants also performed supervised cycle ergometer exercise twice weekly for 30 minutes per session, including warm-up and cool-down periods, together with upper-extremity and shoulder-girdle strengthening exercises.
Participants performed a home-based conventional exercise program. Exercise instructions were provided through a video recording, and participants attended face-to-face follow-up sessions once weekly.
Change in Pain Intensity Assessed by Visual Analog Scale (VAS)
Pain intensity is assessed using a 0-10 cm Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Changes from baseline are evaluated at Week 8 and Week 12, with Week 12 defined as the primary endpoint.
Time frame: Baseline, Week 8, and Week 12
Change in 6-Minute Walk Distance (6MWD)
Exercise capacity is assessed using the 6-Minute Walk Test (6MWT). The total distance walked during 6 minutes is recorded in meters. Changes from baseline are evaluated at Week 8 and Week 12. Higher walking distances indicate better functional exercise capacity.
Time frame: Baseline, Week 8, and Week 12
Change in Ankylosing Spondylitis Quality of Life (ASQoL) Score
Disease-specific quality of life is assessed using the Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire. The total score ranges from 0 to 18, with higher scores indicating poorer quality of life. Changes from baseline are evaluated at Week 8 and Week 12.
Time frame: Baseline, Week 8, and Week 12
Change in Maximum Voluntary Ventilation (MVV)
Respiratory muscle performance is assessed using Maximum Voluntary Ventilation (MVV), expressed in liters per minute (L/min). Changes from baseline are evaluated at Week 8 and Week 12. Higher MVV values indicate greater maximal ventilatory capacity.
Time frame: Baseline, Week 8, and Week 12
Change in Forced Vital Capacity (FVC)
Forced vital capacity (FVC) is assessed by spirometry and reported both as an absolute volume in liters (L) and as a percentage of the predicted value (% predicted). Changes from baseline are evaluated at Week 8 and Week 12. Higher values generally indicate greater ventilatory capacity.
Time frame: Baseline, Week 8, and Week 12
Change in Forced Expiratory Volume in One Second (FEV1)
Forced expiratory volume in one second (FEV1) is assessed by spirometry and reported both as an absolute volume in liters (L) and as a percentage of the predicted value (% predicted). Changes from baseline are evaluated at Week 8 and Week 12. Higher values generally indicate better expiratory airflow and pulmonary function.
Time frame: Baseline, Week 8, and Week 12
Change in Forced Expiratory Volume in One Second to Forced Vital Capacity Ratio (FEV1/FVC)
The Forced Expiratory Volume in One Second/Forced Vital Capacity (FEV1/FVC) ratio is assessed by spirometry and expressed as a percentage (%). Changes from baseline are evaluated at Week 8 and Week 12. The ratio represents the proportion of the forced vital capacity exhaled during the first second of forced expiration.
Time frame: Baseline, Week 8, and Week 12
Change in Peak Expiratory Flow (PEF)
Peak expiratory flow (PEF) is assessed by spirometry and reported in liters per second (L/s) and as a percentage of the predicted value (% predicted). Changes from baseline are evaluated at Week 8 and Week 12. Higher values indicate greater maximal expiratory flow.
Time frame: Baseline, Week 8, and Week 12
Change in Chest Expansion
Chest expansion is assessed as the difference between chest circumference during maximal inspiration and maximal expiration and is expressed in centimeters (cm). Changes from baseline are evaluated at Week 8 and Week 12. Higher values indicate greater thoracic mobility.
Time frame: Baseline, Week 8, and Week 12
Change in Modified Schober Test
Lumbar spine mobility is assessed using the Modified Schober Test and is expressed in centimeters (cm). Changes from baseline are evaluated at Week 8 and Week 12. Higher values indicate greater lumbar flexion mobility.
Time frame: Baseline, Week 8, and Week 12
Change in Occiput-to-Wall Distance
Postural and cervical spine mobility is assessed using the occiput-to-wall distance and is expressed in centimeters (cm). Changes from baseline are evaluated at Week 8 and Week 12. Lower values indicate better postural alignment and spinal mobility.
Time frame: Baseline, Week 8, and Week 12
Change in Lateral Spinal Flexion
Spinal mobility is assessed using the lateral spinal flexion test and is expressed in centimeters (cm). Changes from baseline are evaluated at Week 8 and Week 12. Higher values indicate greater lateral spinal mobility.
Time frame: Baseline, Week 8, and Week 12
Change in Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Score
Disease activity is assessed using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). The total score ranges from 0 to 10, with higher scores indicating greater disease activity. Changes from baseline are evaluated at Week 8 and Week 12.
Time frame: Baseline, Week 8, and Week 12
Change in C-Reactive Protein (CRP) Level
Systemic inflammation is assessed by serum C-reactive protein (CRP) level, expressed in milligrams per liter (mg/L). Changes from baseline are evaluated at Week 8 and Week 12. Higher CRP levels indicate greater systemic inflammation.
Time frame: Baseline, Week 8, and Week 12
Plan to share: No — Individual participant data (IPD) will not be shared because no data-sharing plan was specified in the study protocol or informed consent process.
No publications or documents are linked to this record.
Ran from Nov 2025 to primary completion in Oct 2026, 11 months.
Of 62 non-industry interventional studies with no phase under Spondylitis, Ankylosing, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 20. This study's 11 months is close to that.
Counting every sponsor, half of 65 studies reached it within 12 months; a quarter within 7 and three quarters within 20.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sisli Hamidiye Etfal Training and Research Hospital →